Integrated Filing — IndAS



General information about company

Scrip Code 512529
NSE Symbol VIYASH
MSEI Symbol NA
ISIN INE807F01027
Name of company Viyash Scientific limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 19-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 12-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 19-05-2026   15:00:00
End date and time of board meeting 19-05-2026   16:56:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 05-02-2026
Indicate Company website link for updated RPT policy of the Company https://viyash.com/static/media/policy-related-party-transactions.5bc5b2e603c734a89687.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 37,249.00 1,38,206.00
Other income 1,975.00 6,626.00
Total income 39,224.00 1,44,832.00
2 Expenses
(a) Cost of materials consumed 15,616.00 59,982.00
(b) Purchases of stock-in-trade 1,821.00 2,841.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (404.00) (436.00)
(d) Employee benefit expense 5,745.00 21,375.00
(e) Finance costs 253.00 1,621.00
(f) Depreciation, depletion and amortisation expense 3,116.00 12,415.00
(f) Other Expenses
1 Conversion and processing charges 165.00 477.00
2 Other expenses 8,037.00 30,514.00
Total other expenses 8,202.00 30,991.00
Total expenses 34,349.00 1,28,789.00
3 Total profit before exceptional items and tax 4,875.00 16,043.00
4 Exceptional items 0.00 (4,421.00)
5 Total profit before tax 4,875.00 11,622.00
6 Tax expense
7 Current tax 1,498.00 1,521.00
8 Deferred tax (204.00) 2,514.00
9 Total tax expenses 1,294.00 4,035.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 3,581.00 7,587.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 3,581.00 7,587.00
17 Other comprehensive income net of taxes (80.00) (98.00)
18 Total Comprehensive Income for the period 3,501.00 7,489.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 8,737.00 8,737.00
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 3,10,170.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.82 1.75
Diluted earnings (loss) per share from continuing operations 0.81 1.72
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.82 1.75
Diluted earnings (loss) per share from continuing and discontinued operations 0.81 1.72
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 80,272.00
Capital work-in-progress 5,542.00
Investment property 0.00
Goodwill 33,470.00
Other intangible assets 2,498.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 97,682.00
Trade receivables, non-current 0.00
Loans, non-current 47,397.00
Other non-current financial assets
1 Other non-current financial assets 1,191.00
Total of other non-current financial assets 1,191.00
Total non-current financial assets 1,46,270.00
Deferred tax assets (net)
Other non-current assets
1 Income tax assets (net) 910.00
2 Other non-current assets 297.00
Total of other non-current assets 1,207.00
Total non-current assets 2,69,259.00
2 Current assets
Inventories 29,287.00
Current financial asset
Current investments 5.00
Trade receivables, current 55,426.00
Cash and cash equivalents 2,097.00
Bank balance other than cash and cash equivalents 1,405.00
Loans, current 1.00
Other current financial assets
Total of other current financial assets 79.00
Total current financial assets 59,013.00
Current tax assets (net)
Other current assets
1 Other current assets 7,945.00
Total of other current assets 7,945.00
Total current assets 96,245.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 3,65,504.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 8,737.00
Other equity 3,10,170.00
Total equity attributable to owners of parent 3,18,907.00
Non controlling interest
Total equity 3,18,907.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 632.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease liabilities 2.00
2 Other financial liabilities 108.00
Total of other non-current financial liabilities 110.00
Total non-current financial liabilities 742.00
Provisions, non-current 1,731.00
Deferred tax liabilities (net) 2,541.00
Deferred government grants, Non-current
Other non-current liabilities
1 Other non-current liabilities 6.00
Total of other non-current liabilities 6.00
Total non-current liabilities 5,020.00
Current liabilities
Current financial liabilities
Borrowings, current 2,580.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,404.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 28,651.00
Total Trade payable 31,055.00
Other current financial liabilities
1 Lease liabilities 41.00
2 Other financial liabilities 4,737.00
Total of other current financial liabilities 4,778.00
Total current financial liabilities 38,413.00
Other current liabilities 1,703.00
1 Other current liabilities 1,703.00
Total of other current liabilities 1,703.00
Provisions, current 613.00
Current tax liabilities (Net) 848.00
Deferred government grants, Current
Total current liabilities 41,577.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 46,597.00
Total equity and liabilites 3,65,504.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement loss on defined benefits plans (106.00) (130.00)
2 Fair value gain / (loss) from investment in equity instruments (3.00) (2.00)
Total Amount of items that will not be reclassified to profit and loss (109.00) (132.00)
2 Income tax relating to items that will not be reclassified to profit or loss (29.00) (34.00)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (80.00) (98.00)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 11,622.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1,621.00
Adjustments for decrease (increase) in inventories (1,427.00)
Adjustments for decrease (increase) in trade receivables, current (7,937.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (3,871.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 12,415.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (811.00)
Adjustments for dividend income 0.00
Adjustments for interest income 4,148.00
Adjustments for share-based payments 1,341.00
Adjustments for fair value losses (gains) (56.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (340.00)
Other adjustments to reconcile profit (loss) 212.00
Other adjustments for non-cash items 4,421.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 1,420.00
Net cash flows from (used in) operations 13,042.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 1,130.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 11,912.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 3,221.00
Purchase of property, plant and equipment 10,093.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 4,150.00
Cash receipts from repayment of advances and loans made to other parties 2.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 591.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (259.00)
Net cash flows from (used in) investing activities (10,688.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 3,948.00
Proceeds from issuing other equity instruments 9,252.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 3,994.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 112.00
Repayments of borrowings 16,264.00
Payments of lease liabilities 0.00
Dividends paid 0.00
Interest paid 1,621.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (127.00)
Net cash flows from (used in) financing activities (706.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 518.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 518.00
Cash and cash equivalents cash flow statement at beginning of period 1,579.00
Cash and cash equivalents cash flow statement at end of period 2,097.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 SRBC & Co. LLP Yes 28-02-2029


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Analytical charges 210.00 NA 210.00 0.00 0.00
2 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Analytical charges 35.70 NA 35.70 0.00 0.00
3 Fendigo SA, Belgium Fendigo BV, Netherland Fellow subsidiary Any other transaction Commission expenses 814.70 NA 814.70 0.00 0.00
4 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction cost of sales 1,318.50 NA 1,318.50 0.00 0.00
5 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction cost of sales 44.50 NA 44.50 0.00 0.00
6 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Freight and forwarding 66.40 NA 66.40 0.00 0.00
7 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Freight and forwarding 0.20 NA 0.20 0.00 0.00
8 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Miscellaneous Income 90.90 NA 90.90 0.00 0.00
9 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Miscellaneous Income 210.40 NA 210.40 0.00 0.00
10 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Miscellaneous Income 152.70 NA 152.70 0.00 0.00
11 Viyash Scientific Limited, India Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Miscellaneous Income 28.90 NA 28.90 0.00 0.00
12 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Other borrowing costs 95.00 NA 95.00 0.00 0.00
13 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Other borrowing costs 10.50 NA 10.50 0.00 0.00
14 Alivira Animal Health Limited, Ireland Viyash Scientific Limited, India Ultimate Holding company Any other transaction Other borrowing costs 28.20 NA 28.20 0.00 0.00
15 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Other borrowing costs 19.00 NA 19.00 0.00 0.00
16 Alivira Saude Animal Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Expenses 0.20 NA 0.20 0.00 0.00
17 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Other Expenses 23.20 NA 23.20 0.00 0.00
18 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Other Expenses 94.70 NA 94.70 0.00 0.00
19 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction other income 69.10 NA 69.10 0.00 0.00
20 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction other income 1.40 NA 1.40 0.00 0.00
21 Alivira Animal Health Limited, Ireland Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Step down subsidiary Any other transaction other income 11.30 NA 11.30 0.00 0.00
22 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Any other transaction other income 11.30 NA 11.30 0.00 0.00
23 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction other income 94.50 NA 94.50 0.00 0.00
24 Fendigo SA, Belgium Fendigo BV, Netherland Fellow subsidiary Any other transaction other income 110.30 NA 110.30 0.00 0.00
25 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Any other transaction other income 6.80 NA 6.80 0.00 0.00
26 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Miscellaneous Income 814.70 NA 814.70 0.00 0.00
27 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Miscellaneous Income 264.00 NA 264.00 0.00 0.00
28 Laboratorios Karizoo, S.A., Spain Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Miscellaneous Income 1.30 NA 1.30 0.00 0.00
29 Laboratorios Karizoo, S.A., Spain Alivira Saude Animal Brasil Participacoes Ltda Fellow subsidiary Any other transaction Miscellaneous Income 49.80 NA 49.80 0.00 0.00
30 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Miscellaneous Income 5.00 NA 5.00 0.00 0.00
31 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Any other transaction Miscellaneous Income 63.20 NA 63.20 0.00 0.00
32 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Miscellaneous Income 92.20 NA 92.20 0.00 0.00
33 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Miscellaneous Income 110.20 NA 110.20 0.00 0.00
34 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Miscellaneous Income 1,565.10 NA 1,565.10 0.00 0.00
35 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Professional fees 58.30 NA 58.30 0.00 0.00
36 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Professional fees 114.00 NA 114.00 0.00 0.00
37 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Professional fees 78.50 NA 78.50 0.00 0.00
38 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Any other transaction Professional fees 125.90 NA 125.90 0.00 0.00
39 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Professional fees 255.60 NA 255.60 0.00 0.00
40 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Professional fees 1.90 NA 1.90 0.00 0.00
41 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 18.50 NA 18.50 0.00 0.00
42 Alivira Saude Animal Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 1.60 NA 1.60 0.00 0.00
43 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 5.00 NA 5.00 0.00 0.00
44 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Professional fees 11.30 NA 11.30 0.00 0.00
45 Fendigo SA, Belgium Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 58.90 NA 58.90 0.00 0.00
46 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Professional fees 20.80 NA 20.80 0.00 0.00
47 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 63.20 NA 63.20 0.00 0.00
48 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Professional fees 128.80 NA 128.80 0.00 0.00
49 N-Vet AB, Sweden Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 12.80 NA 12.80 0.00 0.00
50 Phytotherapic Solutions S.L., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Professional fees 16.00 NA 16.00 0.00 0.00
51 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Professional fees 1.00 NA 1.00 0.00 0.00
52 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 1.40 NA 1.40 0.00 0.00
53 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Professional fees 280.00 NA 280.00 0.00 0.00
54 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Professional fees 79.80 NA 79.80 0.00 0.00
55 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional fees 74.90 NA 74.90 0.00 0.00
56 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Research & Development expenses 177.80 NA 177.80 0.00 0.00
57 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Research & Development expenses 150.40 NA 150.40 0.00 0.00
58 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Rent 57.70 NA 57.70 0.00 0.00
59 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Rent 6.70 NA 6.70 0.00 0.00
60 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Other oprating income 125.80 NA 125.80 0.00 0.00
61 Alivira Animal Health Limited, India Rajaram Narayanan Managing Director Any other transaction Remuneration 66.50 NA 66.50 0.00 0.00
62 Viyash Scientific Limited, India Rajaram Narayanan Managing Director Any other transaction Remuneration 100.20 NA 100.20 0.00 0.00
63 Viyash Scientific Limited, India Saurav Bhala Chief Financial Officer Any other transaction Remuneration 63.90 NA 63.90 0.00 0.00
64 Viyash Scientific Limited, India Dr Kamal Sharma Independent Directors Any other transaction Director sitting Fees 16.00 NA 16.00 0.00 0.00
65 Viyash Scientific Limited, India Milind Sarwate Independent Directors Any other transaction Director sitting Fees 14.00 NA 14.00 0.00 0.00
66 Viyash Scientific Limited, India Revati Kasture Independent Directors Any other transaction Director sitting Fees 12.00 NA 12.00 0.00 0.00
67 Viyash Scientific Limited, India Fabian Kausche Non- Executive Directors Any other transaction Director sitting Fees 3.00 NA 3.00 0.00 0.00
68 Viyash Scientific Limited, India Gregory Andrews Non- Executive Directors Any other transaction Director sitting Fees 2.00 NA 2.00 0.00 0.00
69 Viyash Scientific Limited, India Dr. Hari Babu Non- Executive Directors Any other transaction Director sitting Fees 2.00 NA 2.00 0.00 0.00
70 Viyash Scientific Limited, India Yoshita Susmit Vora Company Secretary Any other transaction Remuneration 10.50 NA 10.50 0.00 0.00
71 Alivira Animal Health Limited, India Dr Kamal Sharma Independent Directors Any other transaction Director sitting Fees 3.00 NA 3.00 0.00 0.00
72 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Dividend received 735.10 NA 735.10 0.00 0.00
73 Alivira Animal Health Limited, Ireland Vila Vina Participacions S.L., Spain Subsidiary Dividend received 386.20 NA 386.20 0.00 0.00
74 Alivira Saude Animal Brasil Participacoes Ltda Alivira Saude Animal Ltda, Brazil Subsidiary Dividend received 19.80 NA 19.80 0.00 0.00
75 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Dividend received 471.60 NA 471.60 0.00 0.00
76 Vila Vina Participacions S.L., Spain Phytotherapic Solutions S.L., Spain Subsidiary Dividend received 159.30 NA 159.30 0.00 0.00
77 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Interest paid 2,044.70 NA 2,044.70 0.00 0.00
78 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Interest paid 604.40 NA 604.40 0.00 0.00
79 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Interest paid 10.50 NA 10.50 0.00 0.00
80 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Interest paid 10.80 NA 10.80 0.00 0.00
81 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Holding Interest paid 195.20 NA 195.20 0.00 0.00
82 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Interest paid 586.90 NA 586.90 0.00 0.00
83 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Interest paid 144.20 NA 144.20 0.00 0.00
84 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Interest paid 16.90 NA 16.90 0.00 0.00
85 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Interest paid 151.20 NA 151.20 0.00 0.00
86 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Holding Interest paid 166.20 NA 166.20 0.00 0.00
87 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Interest received 615.50 NA 615.50 0.00 0.00
88 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Wholly owned subsidiary Interest received 201.40 NA 201.40 0.00 0.00
89 Alivira Animal Health Limited, Ireland Alivira Saude Animal Brasil Participacoes Ltda Wholly owned subsidiary Interest received 595.10 NA 595.10 0.00 0.00
90 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Interest received 144.40 NA 144.40 0.00 0.00
91 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Interest received 93.00 NA 93.00 0.00 0.00
92 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Interest received 138.70 NA 138.70 0.00 0.00
93 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Interest received 10.50 NA 10.50 0.00 0.00
94 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Holding Interest received 10.90 NA 10.90 0.00 0.00
95 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Interest received 2,044.70 NA 2,044.70 0.00 0.00
96 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Interest received 16.90 NA 16.90 0.00 0.00
97 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Purchase of goods or services 3,497.70 NA 3,497.70 0.00 0.00
98 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Purchase of goods or services 1,146.00 NA 1,146.00 0.00 0.00
99 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 457.00 NA 457.00 0.00 0.00
100 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 34.80 NA 34.80 0.00 0.00
101 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow subsidiary Purchase of goods or services 3,976.10 NA 3,976.10 0.00 0.00
102 Fendigo SA, Belgium Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 508.90 NA 508.90 0.00 0.00
103 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Purchase of goods or services 967.40 NA 967.40 0.00 0.00
104 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, India Intermediary holding Purchase of goods or services 522.20 NA 522.20 0.00 0.00
105 Alivira Saude Animal Ltda, Brazil Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Purchase of goods or services 172.50 NA 172.50 0.00 0.00
106 Bremer Pharma GmbH, Germany Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 11.20 NA 11.20 0.00 0.00
107 Laboratorios Karizoo S.A. de C.V.,Mexico Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 215.40 NA 215.40 0.00 0.00
108 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 639.50 NA 639.50 0.00 0.00
109 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Purchase of goods or services 0.30 NA 0.30 0.00 0.00
110 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 238.10 NA 238.10 0.00 0.00
111 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Intermediary holding Purchase of goods or services 77.30 NA 77.30 0.00 0.00
112 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Purchase of goods or services 999.70 NA 999.70 0.00 0.00
113 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Purchase of goods or services 433.00 NA 433.00 0.00 0.00
114 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Purchase of goods or services 1,188.90 NA 1,188.90 0.00 0.00
115 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Sale of goods or services 1,306.60 NA 1,306.60 0.00 0.00
116 Alivira Animal Health Limited, India Alivira Saude Animal Ltda, Brazil Step down subsidiary Sale of goods or services 538.70 NA 538.70 0.00 0.00
117 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Step down subsidiary Sale of goods or services 61.20 NA 61.20 0.00 0.00
118 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Sale of goods or services 521.60 NA 521.60 0.00 0.00
119 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Sale of goods or services 130.30 NA 130.30 0.00 0.00
120 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Sale of goods or services 3,976.10 NA 3,976.10 0.00 0.00
121 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Sale of goods or services 475.40 NA 475.40 0.00 0.00
122 Laboratorios Karizoo, S.A., Spain Fendigo SA, Belgium Fellow subsidiary Sale of goods or services 567.80 NA 567.80 0.00 0.00
123 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Sale of goods or services 178.70 NA 178.70 0.00 0.00
124 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Sale of goods or services 117.70 NA 117.70 0.00 0.00
125 Phytotherapic Solutions S.L., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Sale of goods or services 11.20 NA 11.20 0.00 0.00
126 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Sale of goods or services 215.40 NA 215.40 0.00 0.00
127 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Sale of goods or services 639.50 NA 639.50 0.00 0.00
128 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Intermediary holding Sale of goods or services 0.90 NA 0.90 0.00 0.00
129 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Saude Animal Ltda, Brazil Fellow subsidiary Sale of goods or services 198.10 NA 198.10 0.00 0.00
130 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Sale of goods or services 0.40 NA 0.40 0.00 0.00
131 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Sale of goods or services 1,208.30 NA 1,208.30 0.00 0.00
132 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Sale of goods or services 4,719.70 NA 4,719.70 0.00 0.00
133 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Sale of goods or services 1,013.20 NA 1,013.20 0.00 0.00
134 Laboratorios Karizoo, S.A., Spain N-Vet AB, Sweden Fellow subsidiary Sale of goods or services 11.90 NA 11.90 0.00 0.00
135 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Sale of goods or services 1.40 NA 1.40 0.00 0.00
136 Laboratorios Karizoo, S.A., Spain Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Fellow subsidiary Sale of goods or services 64.00 NA 64.00 0.00 0.00
137 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Sale of goods or services 128.60 NA 128.60 0.00 0.00
138 Vila Vina Participacions S.L., Spain Phytotherapic Solutions S.L., Spain Subsidiary Sale of goods or services 16.00 NA 16.00 0.00 0.00
139 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Dividend paid 798.90 NA 798.90 0.00 0.00
140 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Holding Dividend paid 0.40 NA 0.40 0.00 0.00
141 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Dividend paid 508.80 NA 508.80 0.00 0.00
142 Phytotherapic Solutions S.L., Spain Vila Vina Participacions S.L., Spain Holding Dividend paid 173.10 NA 173.10 0.00 0.00
143 Vila Vina Participacions S.L., Spain Alivira Animal Health Limited, Ireland Holding Dividend paid 409.60 NA 409.60 0.00 0.00
144 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Analytical Charges 0.40 NA 0.40 0.00 0.00
145 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Analytical Charges 0.10 NA 0.10 0.00 0.00
146 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Commission expenses 213.20 NA 213.20 0.00 0.00
147 Phytotherapic Solutions S.L., Spain Fendigo SA, Belgium Fellow subsidiary Any other transaction Commission expenses 4.10 NA 4.10 0.00 0.00
148 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Contract Labour 372.90 NA 372.90 0.00 0.00
149 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Dividend received 246.30 NA 246.30 0.00 0.00
150 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Dividend received 0.80 NA 0.80 0.00 0.00
151 Alivira Animal Health Limited, Ireland N-Vet AB, Sweden Wholly owned subsidiary Interest paid 1.80 NA 1.80 0.00 0.00
152 Alivira Italia S.R.L. Vila Vina Participacions S.L., Spain Fellow subsidiary Interest paid 3.10 NA 3.10 0.00 0.00
153 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Interest paid 1.70 NA 1.70 0.00 0.00
154 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Interest paid 13.30 NA 13.30 0.00 0.00
155 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Interest received 1.70 NA 1.70 0.00 0.00
156 N-Vet AB, Sweden Alivira Animal Health Limited, Ireland Holding Interest received 1.80 NA 1.80 0.00 0.00
157 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Interest received 13.30 NA 13.30 0.00 0.00
158 Vila Vina Participacions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Interest received 3.10 NA 3.10 0.00 0.00
159 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Other Expenses 11.30 NA 11.30 0.00 0.00
160 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Other Expenses 19.50 NA 19.50 0.00 0.00
161 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Animal Health Limited, Ireland Holding Any other transaction Other Expenses 15.30 NA 15.30 0.00 0.00
162 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Expenses 60.10 NA 60.10 0.00 0.00
163 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Expenses 1.80 NA 1.80 0.00 0.00
164 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Expenses 0.50 NA 0.50 0.00 0.00
165 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Other Expenses 6.20 NA 6.20 0.00 0.00
166 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Other Expenses 0.30 NA 0.30 0.00 0.00
167 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Other Expenses 0.30 NA 0.30 0.00 0.00
168 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Other Expenses 0.50 NA 0.50 0.00 0.00
169 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Expenses 0.10 NA 0.10 0.00 0.00
170 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Expenses 5.80 NA 5.80 0.00 0.00
171 Phytotherapic Solutions S.L., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Other Expenses 2.60 NA 2.60 0.00 0.00
172 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Any other transaction other income 85.90 NA 85.90 0.00 0.00
173 Fendigo SA, Belgium Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction other income 4.10 NA 4.10 0.00 0.00
174 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction other income 6.10 NA 6.10 0.00 0.00
175 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction other income 6.20 NA 6.20 0.00 0.00
176 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction other income 6.20 NA 6.20 0.00 0.00
177 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction other income 114.00 NA 114.00 0.00 0.00
178 Vila Vina Participacions S.L., Spain Phytotherapic Solutions S.L., Spain Subsidiary Any other transaction other income 2.60 NA 2.60 0.00 0.00
179 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Opertg Rev 1.20 NA 1.20 0.00 0.00
180 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Other Opertg Rev 19.70 NA 19.70 0.00 0.00
181 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Other Opertg Rev 0.10 NA 0.10 0.00 0.00
182 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Other Opertg Rev 5.80 NA 5.80 0.00 0.00
183 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Intermediary holding Any other transaction Other Opertg Rev 0.70 NA 0.70 0.00 0.00
184 Laboratorios Karizoo, S.A., Spain Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Other Opertg Rev 60.90 NA 60.90 0.00 0.00
185 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Other Opertg Rev 7.50 NA 7.50 0.00 0.00
186 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Other Opertg Rev 1.00 NA 1.00 0.00 0.00
187 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Other Opertg Rev 14.50 NA 14.50 0.00 0.00
188 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Other Opertg Rev 1.40 NA 1.40 0.00 0.00
189 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Other Opertg Rev 101.20 NA 101.20 0.00 0.00
190 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Other Opertg Rev 10.00 NA 10.00 0.00 0.00
191 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Other Opertg Rev 50.90 NA 50.90 0.00 0.00
192 Alivira Animal Health Limited, Ireland Viyash Scientific Limited, India Ultimate Holding company Purchase of goods or services 267.20 NA 267.20 0.00 0.00
193 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Purchase of goods or services 107.40 NA 107.40 0.00 0.00
194 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Step down subsidiary Purchase of goods or services 1.20 NA 1.20 0.00 0.00
195 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Animal Health Limited, Ireland Holding Purchase of goods or services 6.20 NA 6.20 0.00 0.00
196 Laboratorios Karizoo S.A. de C.V.,Mexico Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Purchase of goods or services 76.00 NA 76.00 0.00 0.00
197 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Purchase of goods or services 316.00 NA 316.00 0.00 0.00
198 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Intermediary holding Purchase of goods or services 20.70 NA 20.70 0.00 0.00
199 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Research & Development expenses 8.20 NA 8.20 0.00 0.00
200 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Rent 6.10 NA 6.10 0.00 0.00
201 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Rent 101.20 NA 101.20 0.00 0.00
202 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Rent 12.90 NA 12.90 0.00 0.00
203 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Any other transaction Rent 6.20 NA 6.20 0.00 0.00
204 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Step down subsidiary Sale of goods or services 18.10 NA 18.10 0.00 0.00
205 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow subsidiary Sale of goods or services 316.00 NA 316.00 0.00 0.00
206 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Sale of goods or services 0.40 NA 0.40 0.00 0.00
207 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Sale of goods or services 76.00 NA 76.00 0.00 0.00
208 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Sale of goods or services 10.10 NA 10.10 0.00 0.00
209 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Sale of goods or services 111.30 NA 111.30 0.00 0.00
210 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Sale of goods or services 14.80 NA 14.80 0.00 0.00
211 Viyash Scientific Limited, India Alivira Animal Health Limited, Ireland Ultimate Holding company Sale of goods or services 270.70 NA 270.70 0.00 0.00
212 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Sale of goods or services 1.80 NA 1.80 0.00 0.00
213 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Sale of goods or services 0.50 NA 0.50 0.00 0.00
214 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Travel expenses 0.60 NA 0.60 0.00 0.00
215 Viyash Scientific Limited, India Aterna Labs Private Limited Other related party Purchase of goods or services 251.40 NA 251.40 0.00 0.00
216 Viyash Scientific Limited, India Aterna Labs Private Limited Other related party Sale of goods or services 12.50 NA 12.50 0.00 0.00
217 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Brasil Participacoes Ltda Holding Dividend paid 22.60 NA 22.60 0.00 0.00
218 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Dividend paid 261.60 NA 261.60 0.00 0.00
219 APPCO PHARMA LLC Viyash Scientific Limited, India Holding Purchase of goods or services 3,733.50 NA 3,733.50 0.00 0.00
220 APPCO PHARMA LLC Viyash Scientific Limited, India Holding Purchase of goods or services 144.70 NA 144.70 0.00 0.00
221 APPCO PHARMA LLC Viyash Scientific Limited, India Holding Purchase of goods or services 1,570.80 NA 1,570.80 0.00 0.00
222 Viyash Scientific Limited, India APPCO PHARMA LLC Subsidiary Sale of goods or services 3,733.50 NA 3,733.50 0.00 0.00
223 Viyash Scientific Limited, India APPCO PHARMA LLC Subsidiary Sale of goods or services 144.70 NA 144.70 0.00 0.00
224 Viyash Scientific Limited, India APPCO PHARMA LLC Subsidiary Sale of goods or services 1,570.80 NA 1,570.80 0.00 0.00
225 Viyash Scientific Limited, India Dr. Hari Babu Bodepudi Group MD and CEO Any other transaction Remuneration 493.40 NA 493.40 0.00 0.00
226 Viyash Scientific Limited, India Ramakant Singani Chief Financial Officer Any other transaction Remuneration 288.10 NA 288.10 0.00 0.00
227 Viyash Scientific Limited, India Srinivas Vasireddy Director Any other transaction Remuneration 210.80 NA 210.80 0.00 0.00
228 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 2,699.90 2,729.10
229 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 2,699.90 2,729.10
230 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 5.10 0.00
231 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Trade Payable 0.00 NA 0.00 61.50 67.00
232 Alivira Animal Health Limited, India Bremer Pharma GmbH, Germany Step down subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.10 0.00
233 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Payable 0.00 NA 0.00 1.20 1.20
234 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Step down subsidiary Any other transaction Trade Payable 0.00 NA 0.00 37.50 0.00
235 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Trade Payable 0.00 NA 0.00 304.70 0.00
236 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Trade Payable 0.00 NA 0.00 3,394.40 8,597.10
237 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Trade Payable 0.00 NA 0.00 1,910.10 1,778.60
238 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Trade Payable 0.00 NA 0.00 23.00 20.90
239 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Any other transaction Trade Payable 0.00 NA 0.00 18.50 152.00
240 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Payable 0.00 NA 0.00 231.60 207.70
241 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0.00 NA 0.00 648.10 650.60
242 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 276.20 445.30
243 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 27.30 14.40
244 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, India Intermediary holding Any other transaction Trade Payable 0.00 NA 0.00 622.20 587.30
245 Alivira Saude Animal Ltda, Brazil Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 64.20 0.00
246 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0.00 NA 0.00 2.70 0.00
247 Alivira Saude Animal Brasil Participacoes Ltda Alivira Saude Animal Ltda, Brazil Wholly owned subsidiary Any other transaction Trade Payable 0.00 NA 0.00 3.40 0.00
248 Alivira Saude Animal Brasil Participacoes Ltda Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 6.00 0.00
249 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0.00 NA 0.00 533.90 285.90
250 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 91.10 0.70
251 Bremer Pharma GmbH, Germany Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 65.10 0.00
252 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 10.20 0.00
253 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0.00 NA 0.00 4.60 1.90
254 Fendigo SA, Belgium Fendigo BV, Netherland Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 103.60 143.40
255 Fendigo SA, Belgium Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 112.10 137.60
256 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 13.80 28.30
257 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 192.10 76.60
258 Laboratorios Karizoo S.A. de C.V.,Mexico Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 583.20 721.80
259 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0.00 NA 0.00 84.70 57.10
260 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 364.00 203.60
261 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 11.20 0.00
262 N-Vet AB, Sweden Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 2.00 3.90
263 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 30.00 34.20
264 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 198.00 54.20
265 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Intermediary holding Any other transaction Trade Payable 0.00 NA 0.00 19.90 34.20
266 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0.00 NA 0.00 17.30 18.10
267 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 408.80 146.70
268 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 55.20 22.00
269 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0.00 NA 0.00 18.20 90.60
270 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 31.50 66.20
271 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 1,883.20 1,364.50
272 Alivira Animal Health Limited, India Alivira Saude Animal Ltda, Brazil Step down subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 588.20 538.70
273 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Step down subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 25.20 53.30
274 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Trade Receivable 0.00 NA 0.00 63.20 70.20
275 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 595.60 612.70
276 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 443.40 194.90
277 Alivira Animal Health Limited, Ireland Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Step down subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 2.70 3.30
278 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 4.50 1.90
279 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 84.20 58.10
280 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 17.30 18.50
281 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 30.00 34.20
282 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 3.40 1.30
283 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable 0.00 NA 0.00 25.10 47.20
284 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 410.30 147.60
285 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable 0.00 NA 0.00 18.50 149.80
286 Fendigo SA, Belgium Fendigo BV, Netherland Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 13.80 28.30
287 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable 0.00 NA 0.00 13.10 11.20
288 Fendigo BV, Netherland Fendigo SA, Belgium Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 103.60 143.40
289 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Intermediary holding Any other transaction Trade Receivable 0.00 NA 0.00 1.90 1.30
290 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable 0.00 NA 0.00 234.00 204.20
291 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 276.20 445.30
292 Laboratorios Karizoo, S.A., Spain Alivira Saude Animal Brasil Participacoes Ltda Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 6.10 6.60
293 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 91.10 0.70
294 Laboratorios Karizoo, S.A., Spain Fendigo SA, Belgium Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 112.10 140.20
295 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 192.10 76.60
296 Laboratorios Karizoo, S.A., Spain N-Vet AB, Sweden Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 2.00 4.10
297 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 198.00 54.20
298 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 55.40 22.20
299 Laboratorios Karizoo, S.A., Spain Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 31.60 66.60
300 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 27.30 14.40
301 Phytotherapic Solutions S.L., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 65.10 0.00
302 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 583.20 721.80
303 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 364.00 203.60
304 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Intermediary holding Any other transaction Trade Receivable 0.00 NA 0.00 38.40 0.00
305 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable 0.00 NA 0.00 64.30 321.90
306 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 64.10 108.60
307 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 10.10 0.00
308 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 11.10 0.00
309 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 304.70 0.00
310 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 3,394.40 8,597.10
311 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Non Current Borrowing 0.00 NA 0.00 188.60 0.00
312 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Non Current Borrowing 0.00 NA 0.00 42,968.30 47,397.10
313 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing 0.00 NA 0.00 103.40 109.10
314 Alivira Italia S.R.L. Vila Vina Participacions S.L., Spain Fellow subsidiary Any other transaction Non Current Borrowing 0.00 NA 0.00 167.30 109.40
315 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing 0.00 NA 0.00 11,166.90 12,419.30
316 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Non Current Borrowing 0.00 NA 0.00 594.40 961.60
317 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Non Current Borrowing 0.00 NA 0.00 793.10 549.60
318 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 13,502.50 15,026.40
319 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances 0.00 NA 0.00 652.60 272.50
320 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 594.40 961.60
321 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 188.60 0.00
322 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 42,968.30 47,397.10
323 Vila Vina Participacions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 167.30 109.40
324 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 793.10 549.60
325 Alivira Animal Health Limited, Ireland Viyash Scientific Limited, India Ultimate Holding company Any other transaction Trade Payable 0.00 NA 0.00 13.90 0.00
326 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Payable 0.00 NA 0.00 125.00 471.50
327 Viyash Scientific Limited, India Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Trade Receivable 0.00 NA 0.00 13.90 345.70
328 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Loans and Advances 0.00 NA 0.00 125.00 0.00
329 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Loans and Advances 0.00 NA 0.00 43.80 0.00
330 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Current Borrowing 0.00 NA 0.00 13,502.50 15,026.40
331 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Any other transaction Current Borrowing 0.00 NA 0.00 438.70 455.40
332 Alivira Animal Health Limited, Ireland N-Vet AB, Sweden Wholly owned subsidiary Any other transaction Current Borrowing 0.00 NA 0.00 131.90 137.60
333 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Any other transaction Current Borrowing 0.00 NA 0.00 652.80 272.00
334 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Holding Any other transaction Current Borrowing 0.00 NA 0.00 4,433.80 4,887.60
335 Alivira Animal Health UK Limited Alivira Animal Health Limited, Ireland Holding Any other transaction Current Borrowing 0.00 NA 0.00 44.80 51.90
336 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Current Borrowing 0.00 NA 0.00 12,467.10 13,188.80
337 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Current Borrowing 0.00 NA 0.00 5,784.30 6,266.20
338 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Current Borrowing 0.00 NA 0.00 2,620.70 2,932.90
339 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Current Borrowing 0.00 NA 0.00 926.00 803.90
340 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 103.50 108.90
341 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Wholly owned subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 4,437.20 4,935.50
342 Alivira Animal Health Limited, Ireland Alivira Saude Animal Brasil Participacoes Ltda Wholly owned subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 11,175.90 12,539.00
343 Alivira Animal Health Limited, Ireland Alivira Animal Health UK Limited Wholly owned subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 43.20 51.90
344 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 12,462.30 13,159.20
345 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 (1,686.90) (1,682.90)
346 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 2,624.20 2,943.20
347 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances 0.00 NA 0.00 416.90 436.00
348 N-Vet AB, Sweden Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances 0.00 NA 0.00 104.20 108.00
349 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Loans and Advances 0.00 NA 0.00 926.00 803.90
350 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Trade Receivable 0.00 NA 0.00 52.20 471.50
351 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Trade Receivable 0.00 NA 0.00 86.30 0.00
352 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Trade Payable 0.00 NA 0.00 292.80 0.00
353 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Trade Payable 0.00 NA 0.00 40.70 0.00
354 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Payable 0.00 NA 0.00 52.20 0.00
355 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Payable 0.00 NA 0.00 86.30 0.00
356 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 292.80 0.00
357 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 40.70 0.00
358 Viyash Scientific Limited, India Milind Sarwate Independent Directors Any other transaction Director commission 0.00 NA 0.00 1.00 0.00
359 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Corporate guarantee given 0.00 NA 0.00 26,500.00 26,500.00
360 Viyash Scientific Limited, India Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Corporate guarantee given 0.00 NA 0.00 24,818.60 24,818.60
361 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Corporate guarantee given 0.00 NA 0.00 3,800.00 3,800.00
362 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable 0.00 NA 0.00 0.00 3.30
363 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.00 6.60
364 Laboratorios Karizoo S.A. de C.V.,Mexico Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.00 66.10
365 Laboratorios Karizoo, S.A., Spain Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 0.00 6.60
366 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 0.00 66.10
367 APPCO PHARMA LLC Viyash Scientific Limited, India Holding Any other transaction Trade Payable 0.00 NA 0.00 0.00 958.50
368 Viyash Scientific Limited, India APPCO PHARMA LLC Subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 0.00 958.50
369 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Claims receivable 0.00 NA 0.00 0.00 5.50
370 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 0.00 92.10
371 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 0.00 29.80
372 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.00 11.00
373 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.00 339.60
374 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.00 1.30
375 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.00 29.80
376 Laboratorios Karizoo, S.A., Spain Fendigo SA, Belgium Fellow subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.00 2.60
377 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Corporate guarantee liability 0.00 NA 0.00 0.00 19.00
378 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Prepaid expenses 0.00 NA 0.00 0.00 88.80
379 Alivira Animal Health Limited, Ireland Viyash Scientific Limited, India Ultimate Holding company Any other transaction Other Current Liabilities 0.00 NA 0.00 0.00 14.80
380 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Corporate guarantee liability 0.00 NA 0.00 0.00 88.80
381 Viyash Scientific Limited, India Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Others current financial assets 0.00 NA 0.00 0.00 14.80
382 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Prepaid expenses 0.00 NA 0.00 0.00 19.00
383 Viyash Scientific Limited, India Aterna Labs Private Limited Other related party Any other transaction Trade Receivable 0.00 NA 0.00 0.00 14.70
384 Viyash Scientific Limited, India Aterna Labs Private Limited Other related party Any other transaction Advance to supplier 0.00 NA 0.00 0.00 600.00
Total value of transaction during the reporting period 67,077.10